Plecanatide vs Noopept
Head-to-head comparison of Plecanatide (Plecanatide) and Noopept (N-phenylacetyl-L-prolylglycine ethyl ester) — benefits, dosing, side effects, research data, and where to buy.
Research Score
| Property | Plecanatide | Noopept |
|---|---|---|
| Category | Gastrointestinal | Cognitive Enhancement |
| Full Name | Plecanatide | N-phenylacetyl-L-prolylglycine ethyl ester |
| Molecular Weight | Approx. 1620 Da | 318.37 Da |
| Half-Life | Local intestinal action; systemic half-life not clinically meaningful | 20-30 minutes |
| Amino Acids | 16 | N/A |
| Typical Dose | 3 mg once daily | 10-30 mg/day |
| Route | Oral | Oral |
| Purity | ≥98% | ≥98% |
| Studies Count | 350 | 60 |
| Research Status | Clinical | Clinical |
Plecanatide Benefits
- ✓improves-stool-frequency
- ✓supports-fluid-secretion
- ✓may-reduce-constipation
- ✓local-gut-action
Noopept Benefits
- ✓memory recall
- ✓learning efficiency
- ✓attention support
- ✓neurotrophic signaling
Plecanatide Dosing
3 mg PO daily|take with or without food|avoid when dehydrated
Noopept Dosing
oral research use|10-30 mg per day in human studies|divided or single daily dosing
Plecanatide Side Effects
- ⚠diarrhea
- ⚠abdominal-discomfort
- ⚠nausea
Noopept Side Effects
- ⚠headache
- ⚠irritability
- ⚠sleep disturbance
Research Overview
Plecanatide
Clinical trials show plecanatide improves constipation outcomes with a generally favorable tolerability profile. Like linaclotide, it acts locally in the intestinal lumen via GC-C signaling rather than systemic hormone effects.
Noopept
Noopept has been reported to increase NGF/BDNF-related signaling and improve performance in tasks involving learning and recall. Evidence includes preclinical studies and small human studies, but the overall literature is still modest compared with mainstream cognitive drugs.
Ready to buy?
Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.